Consistent with that notion, use of selective inhibitors of CDK2 (CVT-313) or CDK4/6 (PD0332991) alone or in combination did not lead to CLL cell apoptosis (data not shown). This evidence concerns the gene CDK4 and B-cell chronic lymphocytic leukemia.